Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Issues Draft Guidance on NASH Drug Development
FDA Issues Draft Guidance on NASH Drug Development
FDA Issues Draft Guidance on NASH Drug Development
Submitted by
admin
on December 3, 2018 - 5:54pm
Source:
RAPS.org
News Tags:
FDA
NASH
Headline:
FDA Issues Draft Guidance on NASH Drug Development
snippet:
The US Food and Drug Administration (FDA) on Monday issued draft guidance on developing drugs to treat patients who have noncirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis.
Do Not Allow Advertisers to Use My Personal information